iXpressGenes Appoints John Schmitt as CEO, Announc | Newswise

iXpressGenes Appoints John Schmitt as CEO, Announc | Newswise

Newswise — HUNTSVILLE, Ala., Dec. 16, 2024– iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder John Schmitt as Chief Executive Officer (CEO) and announce the nationwide launch of its Trauma Autoimmune Indicator (TAI) test, available by Q2 2025. This cutting-edge advancement represents a paradigm shift in trauma detection and prevention, empowering…

Read More
Supercharging Rapeseed: Genetic Insights to Amplif | Newswise

Supercharging Rapeseed: Genetic Insights to Amplif | Newswise

Newswise — Rapeseed is a key source of phytosterols, plant-derived compounds linked to a range of health benefits, including lowering cholesterol and reducing inflammation. Despite their importance, the genetic mechanisms behind phytosterol production in rapeseed remain poorly understood, hindering efforts to maximize the crop’s nutritional potential. Unraveling the genetic control of sterol biosynthesis is critical…

Read More
Rethinking Value Assessment for Orphan Drugs | Newswise

Rethinking Value Assessment for Orphan Drugs | Newswise

Lawrenceville, NJ, USA—December 18, 2024—Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to…

Read More
Children’s Hospital of Philadelphia Researchers  | Newswise

Children’s Hospital of Philadelphia Researchers | Newswise

Newswise — Philadelphia, December 9, 2024 – Researchers from Children’s Hospital of Philadelphia (CHOP) found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that giving the rotavirus vaccine to eligible infants during their hospitalization provides immune benefits that outweigh any risks. The…

Read More
A Cause of Hyperinflammatory Response in Lethal CO | Newswise

A Cause of Hyperinflammatory Response in Lethal CO | Newswise

Newswise — As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children’s Hospital of Philadelphia, the University of Pittsburgh and Weill Cornell Medicine discovered a novel cause of cytokine storm — the extreme inflammatory response associated with increased risk of death in COVID-19 infection. Their findings were reported…

Read More
Mitochondrial Maestro: PtoRFL30 Orchestrates Popla | Newswise

Mitochondrial Maestro: PtoRFL30 Orchestrates Popla | Newswise

Newswise — Wood formation is far from a simple process; it’s a biological symphony requiring flawless coordination between various cellular systems. While mitochondria are best known as cellular “powerhouses,” their deeper roles in plant growth have only recently come into focus. One major gap, however, has been understanding how these organelles contribute to secondary vascular…

Read More
iMerit’s New Copilot for Radiology Accelerates and Simplifies Medical Image Data Annotation | Newswise

iMerit’s New Copilot for Radiology Accelerates and Simplifies Medical Image Data Annotation | Newswise

Newswise — SAN JOSE, Calif., Dec. 1, 2024 /PRNewswire/ — iMerit, a leader in software delivered AI data solutions, has announced the launch of ANCOR, its Annotation Copilot for Radiology. ANCOR, integrated with iMerit’s Ango Hub product, is an AI-driven tool designed to enhance efficiency and accuracy of radiology AI development. ANCOR, released in limited beta for select customers today…

Read More
Children’s Hospital of Philadelphia Researchers  | Newswise

Montefiore Einstein’s Marina Konopleva Joins Bre | Newswise

Newswise — November 12, 2024—(BRONX, NY)— Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for…

Read More